SQZ Biotechnologies Company
NYSE: SQZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Howard Bernstein
- Employees
- 53
- Headquarters
- Watertown, United States
- IPO year
- 2020
- Market cap
- $12.8M
- Website
- https://www.sqzbiotech.com
Loading SQZ…
Loading profile data…Frequently asked questions about SQZ
What does SQZ Biotechnologies Company (SQZ) do?
SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells t...
Where does SQZ trade?
SQZ Biotechnologies Company (SQZ) trades on the New York Stock Exchange.
What sector is SQZ in?
SQZ Biotechnologies Company (SQZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of SQZ Biotechnologies Company?
Howard Bernstein is the chief executive officer of SQZ Biotechnologies Company (SQZ).
Where is SQZ Biotechnologies Company headquartered?
SQZ Biotechnologies Company is headquartered in United States.
Does SQZ pay a dividend?
SQZ Biotechnologies Company (SQZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SQZ go public?
SQZ Biotechnologies Company (SQZ) completed its initial public offering in 2020.